Absci ABSI
NASDAQ ABSI
$11.09 +0.92 (+9.05%)
As of: Nov 9, 2026 · 10:44 AM EST

Absci (ABSI) Asset Writedowns and Impairment (2023)

Updated

Absci (ABSI) reported Asset Writedowns and Impairment of $21.34 million for FY2023.

Analysis

Absci (ABSI) Asset Writedowns and Impairment (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,248.16 Bn 1,221.78 Bn 20.46 Bn
2 Johnson & Johnson 670.28 Bn 590.14 Bn 17.30 Bn
3 AbbVie 514.81 Bn 482.82 Bn 13.12 Bn
4 Merck 363.68 Bn 326.63 Bn 13.19 Bn
5 Novartis Ag 314.66 Bn 287.90 Bn -
6 Astrazeneca 292.36 Bn 266.25 Bn 13.26 Bn
7 Amgen 248.52 Bn 200.18 Bn 7.58 Bn
8 Gilead Sciences 209.74 Bn 184.85 Bn 6.73 Bn
9 Pfizer 165.67 Bn 113.03 Bn 12.56 Bn
10 Absci 1.74 Bn 1.12 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 21.30 Mn
API Access

Absci Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ABSI&period=max&api_key=YOUR_API_KEY